FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4309438082> ?p ?o ?g. }

• W4309438082 abstract "As dual EGFR and VEGFR-2 inhibitors, 22 innovative thiazolidine-2,4-diones were modeled, constructed, and measured for their anticancer performance versus four human neoplasms HCT-116, MCF-7, A549, and HepG2. Molecular docking and MD simulation were performed to inspect the binding technique of the proffered congeners with the EGFR and VEGFR-2 receptors. Evidence realized thanks to the docking inquests was vastly consistent together with that detected through the biological screening. Structures 14a and 14g emerged as the most active compounds toward HCT116 (IC50 = 6.01 and 7.44 µM), MCF-7 (IC50 = 5.77 and 7.23 µM), A549 (IC50 = 5.35 and 5.47 µM) and HepG2 (IC50 = 3.55 and 3.85 µM) tumefaction cells. Compounds 14a and 14g exhibited higher events than sorafenib (IC50 = 5.05, 5.58, 4.04, and 4.00 µM) against HepG2 instead subordinate incidents concerning A549, MCF-7, and HCT116, parallelly. Nevertheless, these compounds signified weightier performance than erlotinib (IC50 = 13.91, 8.20, 5.49, 7.73, and µM), with respect to the four cell lines. Compounds having the best activity against the four cell lines, 12a-f, 13a-d, and 14a-g were chosen to appraise their in vitro VEGFR-2 and EGFRT790M inhibiting activities. The best results were for compounds 14a and 14g compared to sorafenib and erlotinib, respectively, with IC50 values of 0.74 and 0.78 µM and 0.12 and 0.14 µM, respectively. Moreover, 13d, 14a, and 14g showed an adequate in silico calculated ADMET profile. The current investigation presents novel candidates for future optimization to construct mightier and eclectic binary VEGFR-2/EGFRT790M restrainers with higher antitumor effects." @default.
• W4309438082 created "2022-11-27" @default.
• W4309438082 creator A5014847483 @default.
• W4309438082 creator A5018764734 @default.
• W4309438082 creator A5054958910 @default.
• W4309438082 creator A5066270766 @default.
• W4309438082 date "2022-11-20" @default.
• W4309438082 modified "2023-10-14" @default.
• W4309438082 title "Exploration of thiazolidine‐2,4‐diones as tyrosine kinase inhibitors: Design, synthesis, ADMET, docking, and antiproliferative evaluations" @default.
• W4309438082 cites W1416958482 @default.
• W4309438082 cites W1608710587 @default.
• W4309438082 cites W1688725836 @default.
• W4309438082 cites W1964596754 @default.
• W4309438082 cites W1973035839 @default.
• W4309438082 cites W1979332174 @default.
• W4309438082 cites W1979449084 @default.
• W4309438082 cites W1992905076 @default.
• W4309438082 cites W1999845081 @default.
• W4309438082 cites W2009867031 @default.
• W4309438082 cites W2009968499 @default.
• W4309438082 cites W2012516785 @default.
• W4309438082 cites W2012944100 @default.
• W4309438082 cites W2013335792 @default.
• W4309438082 cites W2018711732 @default.
• W4309438082 cites W2056259571 @default.
• W4309438082 cites W2060399971 @default.
• W4309438082 cites W2063302127 @default.
• W4309438082 cites W2071635244 @default.
• W4309438082 cites W2076178766 @default.
• W4309438082 cites W2077218183 @default.
• W4309438082 cites W2085165769 @default.
• W4309438082 cites W2094465598 @default.
• W4309438082 cites W2096786080 @default.
• W4309438082 cites W2114918609 @default.
• W4309438082 cites W2147993766 @default.
• W4309438082 cites W2151178480 @default.
• W4309438082 cites W2156373035 @default.
• W4309438082 cites W2158028016 @default.
• W4309438082 cites W2177929699 @default.
• W4309438082 cites W2206185841 @default.
• W4309438082 cites W2404280981 @default.
• W4309438082 cites W2418046358 @default.
• W4309438082 cites W2473281810 @default.
• W4309438082 cites W2519105450 @default.
• W4309438082 cites W2593093801 @default.
• W4309438082 cites W2734066598 @default.
• W4309438082 cites W2750145485 @default.
• W4309438082 cites W2940507061 @default.
• W4309438082 cites W3033659767 @default.
• W4309438082 cites W3034131973 @default.
• W4309438082 cites W3039947924 @default.
• W4309438082 cites W3092270666 @default.
• W4309438082 cites W3094019790 @default.
• W4309438082 cites W3094082197 @default.
• W4309438082 cites W3095777980 @default.
• W4309438082 cites W3111336007 @default.
• W4309438082 cites W3125341679 @default.
• W4309438082 cites W3183173575 @default.
• W4309438082 cites W3193974056 @default.
• W4309438082 cites W3217001088 @default.
• W4309438082 cites W4225325549 @default.
• W4309438082 cites W4248107770 @default.
• W4309438082 doi "https://doi.org/10.1002/ardp.202200465" @default.
• W4309438082 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36403198" @default.
• W4309438082 hasPublicationYear "2022" @default.
• W4309438082 type Work @default.
• W4309438082 citedByCount "6" @default.
• W4309438082 countsByYear W43094380822023 @default.
• W4309438082 crossrefType "journal-article" @default.
• W4309438082 hasAuthorship W4309438082A5014847483 @default.
• W4309438082 hasAuthorship W4309438082A5018764734 @default.
• W4309438082 hasAuthorship W4309438082A5054958910 @default.
• W4309438082 hasAuthorship W4309438082A5066270766 @default.
• W4309438082 hasConcept C104317684 @default.
• W4309438082 hasConcept C159110408 @default.
• W4309438082 hasConcept C170493617 @default.
• W4309438082 hasConcept C185592680 @default.
• W4309438082 hasConcept C202751555 @default.
• W4309438082 hasConcept C21951064 @default.
• W4309438082 hasConcept C2775905019 @default.
• W4309438082 hasConcept C2776590680 @default.
• W4309438082 hasConcept C2777752497 @default.
• W4309438082 hasConcept C2778019345 @default.
• W4309438082 hasConcept C2778087573 @default.
• W4309438082 hasConcept C2778695046 @default.
• W4309438082 hasConcept C2779438470 @default.
• W4309438082 hasConcept C41685203 @default.
• W4309438082 hasConcept C502942594 @default.
• W4309438082 hasConcept C55493867 @default.
• W4309438082 hasConcept C70721500 @default.
• W4309438082 hasConcept C71240020 @default.
• W4309438082 hasConcept C71924100 @default.
• W4309438082 hasConcept C81729549 @default.
• W4309438082 hasConcept C86803240 @default.
• W4309438082 hasConcept C98274493 @default.
• W4309438082 hasConceptScore W4309438082C104317684 @default.
• W4309438082 hasConceptScore W4309438082C159110408 @default.
• W4309438082 hasConceptScore W4309438082C170493617 @default.
• W4309438082 hasConceptScore W4309438082C185592680 @default.
• W4309438082 hasConceptScore W4309438082C202751555 @default.

• next